Special considerations for the treatment of multiple myeloma according to advanced age, comorbidities, frailty and organ dysfunction.
Fraz MA, Warraich FH, Warraich SU, Tariq MJ, Warraich Z, Khan AY, Usman M, Ijaz A, Tenneti P, Mushtaq A, Akbar F, Shahid Z, Ali Z, Fazeel HM, Rodriguez C, Nasar A, McBride A, Anwer F.
Fraz MA, et al. Among authors: ijaz a.
Crit Rev Oncol Hematol. 2019 May;137:18-26. doi: 10.1016/j.critrevonc.2019.02.011. Epub 2019 Feb 27.
Crit Rev Oncol Hematol. 2019.
PMID: 31014512
Free PMC article.
Review.